Open original FDA record ↗Recall record
- FDA identifier
- Z-1367-2022
- Company in FDA record
- Ortho-Clinical Diagnostics, Inc.
- FDA record creation date
- Jul 12, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
On-Analyzer Stability (OAS) time, supported for 6 weeks; not 8 weeks as is currently stated in the Instructions For Use (IFU).
Source facts
- Action
- Ortho Clinical Diagnostics issued Important Correction Notification letter (CL2022-135) on May 26, 2022. Letter states reason for recall, health risk and action to take: When using VITROS Anti-SARS-CoV-2 IgG Quantitative Reagent Pack, do not store on-analyzer for longer than 6 weeks. " Until a lot update occurs, OAS for VITROS Anti-SARS-CoV-2 IgG Quantitative Reagent Pack will temporarily require manual monitoring and removal of reagent packs from analyzer no longer than 6 weeks after packs have been opened and loaded onto the analyzer. " Complete the enclosed Confirmation of Receipt form no later than June 9, 2022. " Post this notification by each VITROS ECi/ECiQ/3600/5600/XT 7600 System in your laboratory until further notice. " Please forward this notification if VITROS Anti-SARS-CoV-2 IgG Quantitative Reagent Pack was distributed outside of your facility. If you have further questions, please contact Ortho Care Technical Solutions Center at 1-800-421-3311
- Initiated
- 2022-05-26
- Root cause
- Incorrect or no expiration date
- Distribution
- Worldwide distribution - US Nationwide and the countries of Colombia, India, Singapore.
- Recall number
- Z-1367-2022
- Recall status
- Open, Classified
- CDRH record ID
- 194342
- FDA record created
- 2022-07-12
- Recall event number
- 90408